TCL Archive FDA Approves Gemzar For Ovarian Cancer, Contradicting ODAC Recommendation; Continues Agency Trend to Recognize Progression-Free Survival As An Endpoint. July 21, 2006
TCL Archive Cancer Policy: NCAB Recommends Mammograms Every 1 to 2 Years for Average Risk Women 40-49 April 4, 1997
TCL Archive Also AACI honors MIT’s Robert Weinberg. Bernard Fisher wins two awards. November 21, 2003
TCL Archive Tissue of Origin Test Consistent With Diagnosis In Blinded Validation Study January 28, 2011
